Member Info for AngelMarbles

Star this is a Coronavirus genetically engineered with 4 hiv sequences inserted and a known SARS spike protein taken from bats that merged with ace2 receptor .. it is a flu with aids /cancer like killer cells that keep proliferating in the body and overwhelms the immune system ..it a super human flu killer :-). Very wicked .

I can see the benefits
Look at their vast resource..and the global need for it.
Excellent info in this
https://www.tertiaryminerals.com/projects/fluorspar-projects/fluorspar-market

Comeonvog let us know what the free float is standing at currently

Proteome sciences UK is a top player In the neurological market ..big things t come in the future imo
https://coleofduty.com/tag/neurological-biomarkers-market-share/

https://www.mcponline.org/content/18/7/1468
Try this

In one sense we can load up when it dips ..we know this is a good company which hasnt even started to PR its activities and strengths at all ..
How comes this has gone up by a small buy today I'm not sure but imagine when a few investors buy big. This rerates .. all we need is for proteome to up their game and become aware of communication

When it falls.so far it's time to top up, a world.class.company so far ahead of the rest ..like a rollercoaster u have the best rises on the best falls.. wait for yr heart to leap out of your mouth .. youll remember the day u had so much fun and amazement .and hopefully its very soon. we know the product and sales are massive and all the while growing ..those who like to bash ncyt are just a bit green with envy .. keep the faith and we will be rewarded .
Many colloborations r going on. Odx also has connections with ncyt ..their rapid lateral.flow.test linking up to smartphone app technology to track and trace .. we will all be shown clearly what's going on behind the government doors imo

Through the holdings of Vulpes Life Sciences Fund and Vulpes Testudo Fund, Stephen Diggle is interested in 12,179,874 shares, representing approximately 13.16% of the Company's current issued share capital.

He has 13.16 percent
A Wise Diggle brother

Hullabaloo
Hope this works
It's about studying proteins and how they react with other molecules from whatever it may be. Scientists need these to develop their research and come up with accurate specific targeted drugs .
Pdf on mass testing spectrometry means cheaper ways to fulfill pharmas research .

https://drive.google.com/file/d/1fTTeezalqZvrT66RgIAjXf3JSSSfYoYa/view?usp=drivesdk

They r a diversified company. I take the placing as a leap up in discovery with their assets and investment t shareholders .

TMTpro reagents allow complex experimental designs—all with essentially no missing values across the 16 samples and no loss in quantitative integrity.

https://www.researchgate.net/publication/339960738_TMTpro_reagents_a_set_of_isobaric_labeling_mass_tags_enables_simultaneous_proteome-wide_measurements_across_16_samples

If the company get their act together they could shine ..hopefully we can have some update soon and new life resurrected in the form of communication . Ian pike please get Ur Twitter pages up to date and stay on top of all the research and people of importance out there.

Abingdon Health key partner in the UK Rapid Test Consortium (UK-RTC). A group of top UK diagnostics companies formed to develop a COVID-19 Antibody Test APPDX check that outhttps://www.abingdonhealth.com/contract-services/lateral-flow-reader/appdx/Tech for lateral flow data analysis can be incorporated into a customisable app .. technology mixed in with the antibody test is very exciting and huge ! Think of that with allergy and food intolerances as well .

If people only see and research there is actually lots of news to explore ..it's a fantastic share to be in.. they r about allergy and food intolerance and also have hiv rapid test which we know has some sequences in the c19 virus ...the lateral flow test is being incorporated with real time data analysis apps that r customisable on smartphones via Abingdon health .. and others in the consortium , the uni of Oxford will make this a real worthy piece of kit to understand the virus .

I'm sure many of us have food intolerance and I'll was and can't understand what is causing it..they will then b making food intolerances and allergy testing open to market for mass market ..that is massive in its own right, when we can take control of our health and therefore do something about it rather then being in limbo. The health holistic industry is massive.

Yellowstone Advisory Webinar with Christian Hoyer Millar, Director and co-founder at Oxford Biodynamics
May 20, 2020 12:30 PM

London

Webinar ID 827 0318 5109
Christian Hoyer Millar, Director and co-founder at Oxford Biodynamics provides an introduction to the company and updates on recent events.

Oxford BioDynamics Plc is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry.

The Company's award-winning, proprietary technology platform, EpiSwitch™, aims to accelerate the drug discovery and development process, improve the success rate of therapeutic product development and take advantage of the increasing importance of personalised medicine.

In particular, EpiSwitch™ can reduce time to market, failure rates and the costs at every stage of drug discovery. Additionally, the technology provides significant insights into disease mechanisms for drug discovery and product re-positioning programmes, and enables the personalisation of therapeutics for patients in the context of challenging pricing environments where improved clinical outcomes are critical.

Everyone should contact proteome as have I with no response as to their communication ..they haven't posted on twitter since 2017 ..

It's the same with prm proteome sciences again another Diggle brother share ...likewise prms communication and proactivity w investors is abysmal and I can only think it suits their interests...if you read in to the sector the biomarker market r opening up and will b huge for actively targeting diseases specifically and accurately ....so this imo is a hidden gem but u have t be confident in it and call the board t account to their shareholders regarding communication

Absolutely ccards.. fortune favours the bold ye gold diggers .. its hotting up

To get batteries y need the earth's minerals
We are due an update soon 4 those drill results

Scottish-European Growth Co-investment dishes out first round of £16 million fund to tech and data analytics companies

https://digit.fyi/tech-data-firms-first-to-benefit-from-scottish-investment-bank-programme/